ClassID:

96409

C07H17/04 - CPC Classification

Classification description:

Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals Heterocyclic radicals containing only oxygen as ring hetero atoms

Sub-classes:
Recent Application in this class:
#1
20260125411
2026-05-07

COMPOUND EMITTING LIGHT UNDER SPECIFIC CONDITIONS, AND METHOD FOR DETECTING CANCER STEM CELLS USING SAME

#2
20260062435
2026-03-05

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

#3
20250340581
2025-11-06

PAEONIFLORIN MONOHYDRATE CRYSTAL FORM A, PREPARATION METHOD THEREFOR, AND USE THEREOF

#4
20250332271
2025-10-30

PROGRAMMABLE SELECTIVE ACYLATION OF POLYOLS

#5
20250179122
2025-06-05

Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the Same

#6
20250074932
2025-03-06

CATALYTIC STEREOSELECTIVE GLYCOSYLATION

#7
20240327388
2024-10-03

QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS

#8
20240272146
2024-08-15

CHROMOGENIC AND FLUOROGENIC COMPOUNDS AND THEIR USE FOR BIOLOGICAL DETECTION

#9
20240270781
2024-08-15

PREPARATION METHOD OF PAEONIFLORIN-6'-O-BENZENE SULFONATE

#10
20240148038
2024-05-09

TASTE-MASKING COMPOUNDS AND COMPOSITIONS AND USES THEREOF

#11
20240109931
2024-04-04

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

#12
20240067634
2024-02-29

INHIBITORS OF NEF DOWNMODULATION

#13
20230348518
2023-11-02

HELICASE INHIBITORS FOR TREATMENT OF MEDICAL DISORDERS

#14
20230192748
2023-06-22

Etoposide Glycosides, Methods Of Making, And Uses Thereof As An Anti-Cancer Drug

#15
20230138729
2023-05-04

Coumarin Derivatives of Sugar Analogs and Uses Thereof

#16
20230119068
2023-04-20

METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS

#17
20230092001
2023-03-23

Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof

#18
20230086494
2023-03-23

Flavor composition containing HMG glucosides

#19
20230086354
2023-03-23

GLUCOPYRANOSYL DERIVATIVES AND THEIR USES

#20
20230045939
2023-02-16

Stable vaccine against

#21
20220380398
2022-12-01

MANGIFERIN AND PREPARATION METHOD THEREOF

#22
20220378920
2022-12-01

CONJUGATE OF GalNAc-OLIGONUCLEOTIDE FOR DELIVERY TO LIVER AND MANUFACTURING METHOD THEREOF

#23
20220324898
2022-10-13

PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS COMPRISING AN AMYLASE CLEAVABLE LINKER

#24
20220186286
2022-06-16

FLUORESCENT PROBE FOR DETECTING ACTIVATION OF SIALIDASE

#25
20220153773
2022-05-19

A CRYSTALLINE POTASSIUM SALT OF 2-O-ALPHA-D-GLUCOSYL-LASCORBIC ACID AND METHOD FOR PRODUCING THE SAME

#26
20220110962
2022-04-14

ANALOGUES OF OLEUROPEIN AND OLEACEIN AND USES THEREOF

#27
20220098228
2022-03-31

METHODS AND COMPOSITIONS FOR IMPROVING THE IMMUNE SYSTEM AND PROVIDING IMMUNO-PROTECTION

#28
20220089631
2022-03-24

COMPOUND COMPRISING MULTIVALENT SIALYLOLIGOSACCHARIDE RESIDUES, AND COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTION DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT

#29
20210323991
2021-10-21

Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors

#30
20210317492
2021-10-14

Method for production of sugar alcohol from red algae

#31
20210230206
2021-07-29

Method for separating natural substance mixtures by means of SCPC

#32
20210198305
2021-07-01

OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF

#33
20210171563
2021-06-10

Compounds and methods for treating bacterial infections

#34
20210054011
2021-02-25

Preparation method of high-purity total ginkgo flavonol glycoside and application of same

#35
20210023112
2021-01-28

ANALOGUES OF ETOPOSIDE FOR THE TREATMENT OF TUMOURS

#36
20200407346
2020-12-31

Compound having therapeutic activity against mycobacterium avium complex infection, and method for producing same

#37
20200385418
2020-12-10

Antidepressant compound and preparation method and application thereof

#38
20200140474
2020-05-07

Whitening composition containing novel quercetin-based compound

#39
20200131220
2020-04-30

Cyphomycin, compositions and uses thereof

#40
20190375775
2019-12-12

FLAVOR COMPOSITION CONTAINING HMG GLUCOSIDES

#41
20190256544
2019-08-22

Enzyme-specific intracellularly-retained red fluorescent probe

#42
20190125885
2019-05-02

Stabilization of biomolecules using sugar polymers

#43
20180221279
2018-08-09

MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES

#44
20180125873
2018-05-10

Analogues of etoposide for the treatment of tumours

#45
20180105548
2018-04-19

A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof

#46
20180092936
2018-04-05

Process for producing a particulate composition comprising an hydrous crystalline 2-o-alpha-d-glucosyl-ascorbic acid

#47
20170369519
2017-12-28

METHODS FOR THE STEREOSELECTIVE PREPARATION OF APIOSE DERIVATIVES FROM ALLYLIC ALCOHOL COMPOUNDS AND ALLENE COMPOUNDS USING CATALYTIC ASYMMETRIC SYNTHESIS

#48
20170360819
2017-12-21

PROCESS FOR PRODUCING A PARTICULATE COMPOSITION COMPRISING AN HYDROUS CRYSTALLINE 2-O-ALPHA-D-GLUCOSYL-L-ASCORBIC ACID

#49
20170240582
2017-08-24

1,4,7,10-tetrazacyclododecane based agents to target bacteria and its use

#50
20170151271
2017-06-01

Androgen effectors

#51
20170114076
2017-04-27

Podophyllotoxin derivatives and their use

#52
20170073321
2017-03-16

Enzyme-specific fluorescent compound capable of being retained in cells

#53
20160375145
2016-12-29

ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY

#54
20160355537
2016-12-08

Trioxacarcins and uses thereof

#55
20160264609
2016-09-15

Disaccharide intermediate and synthesis method thereof

#56
20160220704
2016-08-04

Pyridazinoindole compounds and methods for PET imaging

#57
20160024131
2016-01-28

Process for producing a particulate composition comprising an hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid

#58
20160015063
2016-01-21

Flavor composition containing HMG glucosides

#59
20150328245
2015-11-19

Agents for Eliminating Tumour-Initiating Cells

#60
20150250169
2015-09-10

ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT

#61
20150218196
2015-08-06

Selective oxidation of carbohydrates

#62
20150212073
2015-07-30

Fluorescent probe

#63
20150197539
2015-07-16

Chartreusin analogues

#64
20150126465
2015-05-07

PROCESS FOR PRODUCING DERIVATIVES OF PYROSTEGIA VENUSTA, DERIVATIVES OF PYROSTEGIA VENUSTA, PHARMACEUTICAL COMPOSITIONS AND ITS USES

#65
20150072952
2015-03-12

Glycomimetics to inhibit pathogen-host interactions

#66
20140377838
2014-12-25

Stabilization of biomolecules using sugar polymers

#67
20140357584
2014-12-04

ARYL NAPHTHALIDE LIGNANS AS ANTI-HIV AGENTS

#68
20140356417
2014-12-04

Modified drugs for use in liposomal nanoparticles

#69
20140348922
2014-11-27

Process for producing a particulate composition comprising an hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid

#70
20140343263
2014-11-20

METHOD TO RECOVER BIOACTIVE COMPOUNDS

#71
20140234912
2014-08-21

Method for generating human milk oligosaccharides (HMOs) or precursors thereof

#72
20140234884
2014-08-21

FLUOROGENIC SUBSTRATES, METHODS OF MAKING THE SUBSTRATES, AND METHODS OF DETECTING GLYCOSIDASE ACTIVITIES

#73
20140228554
2014-08-14

SYNTHESIS OF NEW FUCOSE-CONTAINING CARBOHYDRATE DERIVATIVES

#74
20140228551
2014-08-14

Compositions, methods of synthesis and use of carbohydrate targeted agents

#75
20140193530
2014-07-10

Pharmaceutical composition containing honeysuckle extract and antibiotics, pharmaceutical kit, and use of honeysuckle extract for preparation of drug

#76
20140178943
2014-06-26

Process for producing a particulate composition comprising anhydrous crystalline 2-O-alpha-D-glucosyl-L-ascorbic acid

#77
20140088028
2014-03-27

Selective glycosidase inhibitors and uses thereof

#78
20130274213
2013-10-17

Glycosylated aminocoumarins and methods of preparing and uses of same

#79
20130274212
2013-10-17

Sesterterpene Compounds and Use Thereof

#80
20130231469
2013-09-05

Method for preparing albiflorin and paeoniflorin

#81
20130210705
2013-08-15

Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof

#82
20130172542
2013-07-04

Hydrous crystalline 2-O-α-D-glucosyl-L-ascorbic acid, particulate composition comprising the same, their preparation and uses

#83
20130165397
2013-06-27

Treatment of bacterial infectious diseases

#84
20130157969
2013-06-20

Polyol modified aminoglycoside-lipid conjugates

#85
20130150314
2013-06-13

Trioxacarcins and uses thereof

#86
20130130998
2013-05-23

Analogues of etoposide for the treatment of tumours

#87
20130130997
2013-05-23

C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof

#88
20130039904
2013-02-14

GAMBOGIC ACID CYCLIZATION ANALOGUES, THEIR PREPARATION METHOD AND APPLICATION THEREOF

#89
20120329755
2012-12-27

GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONAS

#90
20120277416
2012-11-01

Cell surface coating with hyaluronic acid oligomer derivative

#91
20120237591
2012-09-20

Modified drugs for use in liposomal nanoparticles

#92
20120232263
2012-09-13

Mimetics of sulfated oligosaccharides

#93
20120232256
2012-09-13

Process for producing 1,2-trans-glycoside compound

#94
20120190633
2012-07-26

Monophosphorylated lipid A derivatives

#95
20120183632
2012-07-19

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#96
20120135914
2012-05-31

Etoposide and doxorubicin conjugates for drug delivery

#97
20120121511
2012-05-17

INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS

#98
20120083594
2012-04-05

Process for the preparation of disaccharides applied to heparin pentasaccharides

#99
20120029179
2012-02-02

PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN

#100
20120004193
2012-01-05

PROCESS FOR PRODUCTION OF ORALLY INGESTIBLE COMPOSITION CONTAINING ARABINOFURANOSYL VITEXIN, AND USE OF THE COMPOSITION

#101
20110312905
2011-12-22

Stimulus-triggered prodrugs

#102
20110165225
2011-07-07

Modified drugs for use in liposomal nanoparticles

#103
20110046081
2011-02-24

Classical cannabinoid metabolites and methods of use thereof

#104
20110009396
2011-01-13

Tricyclic compounds for the treatment of inflammatory disorders

#105
20100286376
2010-11-11

Method to recover bioactive compounds

#106
20100249046
2010-09-30

Mangiferin calcium salts, the method for its preparation and its use

#107
20100227402
2010-09-09

Cell surface coating with hyaluronic acid oligomer derivative

#108
20100216874
2010-08-26

HYDROXYTYROSOL-RICH COMPOSITION FROM OLIVE VEGETATION WATER AND METHOD OF USE THEREOF

#109
20100204464
2010-08-12

ASCORBIC ACID DERIVATIVES, THEIR PREPARATION METHODS, INTERMEDIATES AND USES IN COSMETICS

#110
20100144658
2010-06-10

Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics

#111
20100056773
2010-03-04

DECOLORIZATION OF PROCESS STREAMS BY CHEMICAL OXIDATION IN THE MANUFACTURE OF TRICHLOROGALACTOSUCROSE

#112
20100041626
2010-02-18

Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from

#113
20090324750
2009-12-31

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#114
20090275525
2009-11-05

Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity

#115
20090111975
2009-04-30

Method for the synthesis of anthocyanins

#116
20090105128
2009-04-23

Cannabinoid receptor targeted agent

#117
20090093420
2009-04-09

PROCESSES FOR THE PREPARATION OF AZITHROMYCIN

#118
20090075842
2009-03-19

Neoglycorandomization and digitoxin analogs

#119
20090036386
2009-02-05

Heterobifunctional compounds for selectin inhibition

#120
20080269112
2008-10-30

Antineoplastic Agents Targeted via Glut Transporters

#121
20080188452
2008-08-07

Macrocyclic benzofused pyrimidine derivatives

#122
20080182803
2008-07-31

Rubrofusarin glycoside-containing composition

#123
20080182802
2008-07-31

Spiroheterocyclic glycosides and methods of use

#124
20080177049
2008-07-24

Process for producing 1,2-trans-glycoside compound

#125
20080176818
2008-07-24

Sulfoglycolipid antigens, their extraction from , and their use against tuberculosis

#126
20080090901
2008-04-17

Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities

#127
20080070983
2008-03-20

2-O- (β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it

#128
20080051368
2008-02-28

Process for the isolation and stabilization of low-molecular weight aminoglycans form waste egg shells

#129
20070275006
2007-11-29

IRIDOID GLYCOSIDE COMPOSITION

#130
20070225484
2007-09-27

Process for the Isolation and Stabilization of Low-Molecular Weight Aminoglycans from Waste Egg Shells

#131
20070161598
2007-07-12

Compositions and methods for treatment of disease with acetylated disaccharides

#132
20070148744
2007-06-28

species that produces a bafilomycin-like metabolite

#133
20070148268
2007-06-28

CHEMICAL COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENT AND MEANS OF QUALITY ASSESSMENT OF HERBAL MEDICINES

#134
20070123474
2007-05-31

Loganin analogues and a process for the preparation thereof

#135
20070116665
2007-05-24

Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses

#136
20070111952
2007-05-17

Glycosylated triketide delta lactones

#137
20070065380
2007-03-22

2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it

#138
20070037775
2007-02-15

Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from

#139
20060247179
2006-11-02

Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof

#140
20060199774
2006-09-07

Remedies

#141
20060171893
2006-08-03

Antineoplastic agents targeted via glut transporters

#142
20060110474
2006-05-25

Rubrofusarin glycoside-containing composition

#143
20060057658
2006-03-16

Labeled substrate conjugates for identifying enzyme inhibitors

#144
20050245598
2005-11-03

Bafilomycin-like metabolite from a novel species

#145
20050215492
2005-09-29

Ameliorant for chemical treatment of cancer

#146
20050154215
2005-07-14

Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities

#147
20050143341
2005-06-30

Substance having physiological property, method for producing the same and uses thereof

#148
20050113312
2005-05-26

2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it

#149
20050090431
2005-04-28

Water soluble prodrugs of hindered alcohols

#150
20050070464
2005-03-31

Sialic carbohydrates

#151
20050009759
2005-01-13

Derivatives of etoposide and analogs, and pharmaceutical compositions containing them

#152
16879075
2025-09-02

Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same